Your browser doesn't support javascript.
loading
Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
Azam, James M; Saitta, Barbara; Bonner, Kimberly; Ferrari, Matthew J; Pulliam, Juliet R C.
Afiliación
  • Azam JM; DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa. Electronic address: jamesazam@sun.ac.za.
  • Saitta B; Access Campaign, Médecins Sans Frontières, New York, United States.
  • Bonner K; University of Minnesota, Twin Cities, Minneapolis, United States.
  • Ferrari MJ; The Center for Infectious Disease Dynamics, The Pennsylvania State University, PA, United States.
  • Pulliam JRC; DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
Vaccine ; 39(40): 5845-5853, 2021 09 24.
Article en En | MEDLINE | ID: mdl-34481696
INTRODUCTION: Rapid outbreak response vaccination is a strategy for measles control and elimination. Measles vaccines must be stored and transported within a specified temperature range, but this can present significant challenges when targeting remote populations. Measles vaccine licensure for delivery outside cold chain (OCC) could provide more vaccine transport/storage space without ice packs, and a solution to shorten response times. However, due to vaccine safety and wastage considerations, the OCC strategy will require other operational changes, potentially including the use of 1-dose (monodose) instead of 10-dose vials, requiring larger transport/storage equipment currently achieved with 10-dose vials. These trade-offs require quantitative comparisons of vaccine delivery options to evaluate their relative benefits. METHODS: We developed a modelling framework combining elements of the vaccine supply chain - cold chain, vial, team, and transport equipment types - with a measles transmission dynamics model to compare vaccine delivery options. We compared 10 strategies resulting from combinations of the vaccine supply elements and grouped into three main classes: OCC, partial cold chain (PCC), and full cold chain (FCC). For each strategy, we explored a campaign with 20 teams sequentially targeting 5 locations with 100,000 individuals each. We characterised the time needed to freeze ice packs and complete the campaign (campaign duration), vaccination coverage, and cases averted, assuming a fixed pre-deployment delay before campaign commencement. We performed sensitivity analyses of the pre-deployment delay, population sizes, and two team allocation schemes. RESULTS: The OCC, PCC, and FCC strategies achieve campaign durations of 50, 51, and 52 days, respectively. Nine of the ten strategies can achieve a vaccination coverage of 80%, and OCC averts the most cases. DISCUSSION: The OCC strategy, therefore, presents improved operational and epidemiological outcomes relative to current practice and the other options considered.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_transmissiveis / 1_surtos_doencas_emergencias / 2_enfermedades_transmissibles Asunto principal: Vacuna Antisarampión / Sarampión Límite: Humans Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_transmissiveis / 1_surtos_doencas_emergencias / 2_enfermedades_transmissibles Asunto principal: Vacuna Antisarampión / Sarampión Límite: Humans Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article
...